Follow us on Twitter

Tuesday 4 December 2012

Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate

http://www.globenewswire.com/Tracker?data=loHr-gxXgAa6o3fZKj-GO2rnML4-EE6sEyS71AQoWXnaRi7rW_8NCHMpvbIebOOISwpdD7CrMJ4Ur8nb1qMyIpn4FOFjUoXeD-4wn5d672m6MYDJ6ILI0GR7WEz1Gda5Mus9Es6OaH3Is4BbK9rdAg%3D%3D

Posted by Rob LW

No comments:

Post a Comment